| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Catalent, Inc. | SVP, Ops, Biologics Europe | Common Stock | 5.68K | $211K | $37.18 | May 1, 2023 | Direct |
| Catalent, Inc. | SVP, Ops, Biologics Europe | Options to purchase Common Stock | 3.64K | Jul 26, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CTLT | Catalent, Inc. | May 1, 2023 | 1 | -$33.8K | 4 | May 3, 2023 | SVP, Ops, Biologics Europe |
| CTLT | Catalent, Inc. | Aug 24, 2022 | 2 | -$163K | 4 | Aug 26, 2022 | SVP Global Ops Biologics |
| CTLT | Catalent, Inc. | Jul 26, 2022 | 3 | -$104K | 4 | Jul 28, 2022 | SVP Global Ops Biologics |
| CTLT | Catalent, Inc. | Jun 10, 2022 | 1 | -$12.6K | 4 | Jun 13, 2022 | SVP Global Ops Large Molecule |
| CTLT | Catalent, Inc. | Oct 28, 2021 | 0 | $0 | 3 | Nov 2, 2021 | SVP Global Ops Large Molecule |